ESLA

NASDAQStock

Estrella Immunopharma, Inc.

$1.28+0.04 (+2.80%)

52-Week Range

$0.76

$3.05

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.53

Volume

18.3K

Avg Volume

38.0K

Performance

+1.63%

-30.94%

+18.65%

YTD

-10.07%

+35.87%

-63.98%

Price Chart

ETF Exposure

ESLA is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	26,722	$33K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	13	$20	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	470	$713	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	268,005	$300K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,409	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	121	$184	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	114,464	$128K	$84.10B	0.05%

About ESLA ETF Exposure

Estrella Immunopharma, Inc. (ESLA) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.28. Investors can gain exposure to ESLA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ESLA, sorted by portfolio weight.